Evidence map›Paper›PMID 41807760›Full record

ArticleEMBO reports2026

Minute amounts of helicase-deficient truncated RECQL4 are sufficient for DNA replication.

Paula Armina V Buco, Wilson Castillo-Tandazo, Alistair M Chalk, Courtney Pilcher, Jessica K Holien, Jörg Heierhorst, Tiong Y Tan, Amnon Koren, Monique F Smeets, Carl R Walkley

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Paula Armina V Buco *Centre for Innate Immunity and Infection Diseases, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.ORCID 0009-0008-3451-4188
Wilson Castillo-Tandazo *St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Alistair M ChalkSt Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.ORCID 0000-0002-9630-6236
Courtney PilcherSt Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.ORCID 0000-0003-2264-9719
Jessica K HolienSt Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Jörg HeierhorstSt Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.ORCID 0000-0003-2789-9514
Tiong Y TanVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia.
Amnon KorenDepartment of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA.ORCID 0000-0002-7144-2602
Monique F Smeets *St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.ORCID 0000-0001-6027-4108
Carl R Walkley *Centre for Innate Immunity and Infection Diseases, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia. carl.walkley@hudson.org.au.ORCID 0000-0002-4784-9031

Funding

The Genetic Basis of Human DNA Replication TimingR35GM148071 · NIGMS · ROSWELL PARK CANCER INSTITUTE CORP · PI Amnon Koren · 2023 to 2026
$1.5M
Australian Cancer Research Foundation (ACRF) to Victorian Centre for Functional GenomicsAustralian Government Department of Education to Phenomics Australia (nodes utilised: Monash Genome Modification Platform (MGMP), Monash UniversitAustralian Government (Federal Government) MRF2007435Australian Government's National Collaborative Research Infrastructure Strategy to Victorian Centre for Functional GenomicsDHAC | National Health and Medical Research Council (NHMRC) GNT2018098HHS | National Institutes of Health (NIH) R35GM148071Peter MacCallum Cancer Centre Foundation to Victorian Centre for Functional GenomicsRMIT University (RMIT) Postgraduate scholarshipRMIT University (RMIT) Vice Chancellor's FellowshipState Government of Victoria (VicGovAu) Operational Infrastructure Support Scheme to St Vincent's Institute and Hudson Institute of MedicalSt Vincent's Institute of Medical Research (SVI) Top-up ScholarshipUniversity of Melbourne (UNIMELB) Collaborative Research Infrastructure Program to Victorian Centre for Functional GenomicsUniversity of Melbourne (UNIMELB) Melbourne Research Scholarship
6 · The paper itself

Abstract

RECQL4, a RecQ family helicase, is essential for DNA replication and genome stability. Mutations in RECQL4 cause severe human disorders yet we do not fully understand its functions, particularly regarding ATP-dependent helicase activity. To understand RECQL4's functions further, we performed a genome-wide forward genetic screen using a murine model harbouring patient-like RECQL4 mutations. We identify KLHDC3, a substrate-binding subunit of the Cullin-RING ligase E3 complex, loss as the most significant rescue allele. KLHDC3 loss restores proliferation and replication in RECQL4-deficient cells by stabilizing trace levels of a truncated RECQL4 fragment containing the N-terminal 480 amino acids, lacking the helicase and C-terminal regions. This RECQL4 fragment forms after Cre-mediated recombination of the Recql4

Indexed as

DNA ReplicationRecQ HelicasesAnimalsCell ProliferationCell SurvivalDegronsHumansMiceMutationRecQ HelicasesRECQL4 protein, humanDNA ReplicationRecQRecql4Rothmund-Thomson Syndrome

Identifiers

PMID41807760
PMCPMC13076768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.